Beilner, Daniel
Kuhn, Christina
Kost, Bernd P.
Vilsmaier, Theresa
Vattai, Aurelia
Kaltofen, Till
Mahner, Sven
Schmoeckel, Elisa
Dannecker, Christian
Jückstock, Julia
Mayr, Doris
Jeschke, Udo http://orcid.org/0000-0003-2623-3235
Heidegger, Helene Hildegard
Funding for this research was provided by:
Ludwig-Maximilians-Universität München
Article History
Received: 17 November 2020
Accepted: 27 March 2021
First Online: 16 April 2021
Declarations
:
: SM reports grants and personal fees from AstraZeneca, personal fees from Clovis, grants and personal fees from Medac, grants and personal fees from MSD. He also reports personal fees from Novartis, grants and personal fees from PharmaMar, grants and personal fees from Roche, personal fees from Sensor Kinesis, grants and personal fees from Tesaro, grants and personal fees from Teva, outside the submitted study. Christian Dannecker reports personal fees from MSD, Roche, Sanofi and Tesaro outside the submitted study. All the other authors declare no conflict of interest.
: The specimens were collected for histopathological diagnostics and used for the study after no clinical use was indicated any longer. The patient data were anonymized and blinded for the authors about clinical information at any time during the experimental analysis. The local committee of the Ludwig-Maximilians-University of Munich has approved the study (reference number 259-16, 13 June 2016) and was principled conforming to the Declaration of Helsinki.
: Not applicable.
: The data sets used during the current study are available from the corresponding author on reasonable request.
: Not applicable.